Artera has won FDA clearance for ArteraAI Breast, its breast cancer platform for patients with early-stage HR-positive, HER2-negative invasive breast cancer. ArteraAI Breast is the first...
The World Health Organization (WHO) has launched an AI tool in beta to help policymakers, experts and healthcare professionals access sexual and reproductive health information faster....
Cervical cancer elimination in the EU is becoming achievable as HPV vaccination coverage rises, a new report says. As Europe marks European Immunisation Week 2026, the...
France will reimburse reusable period products for women under 26 and those on low incomes, in a move aimed at tackling period poverty. The measure is...
Mariella Frostrup has been appointed the government’s women’s employment ambassador, a new role to support working women across the UK. The new role comes as the...
Peers are set to debate abortion law changes that would pardon women in England and Wales already criminalised and halt active police investigations. Last summer, MPs...
A new report by Clue has revealed the ‘Cost of Bleeding’ – a deep dive into the true cost of menstruation and the impact of related...
India’s top court rejected a menstrual leave petition for women and female students, saying such a law could mean “no-one will hire women”. The two-judge bench,...
The US Food and Drug Administration (FDA) has granted fast track status to a new drug combination for BRCA-mutated advanced breast cancer. The designation covers ART6043,...
Women spend 25 per cent more of their lives in poor health than men due in part to disproportionately low investment, a new report has revealed....
